As of 2025-07-04, the Fair Value of Immunome Inc (IMNM) is -11.79 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 8.84 USD, the upside of Immunome Inc is -233.33%.
With the market price of 8.84 USD and our fair value calculation, Immunome Inc (IMNM) is not a good investment. Investing in IMNM stocks now will result in a potential loss of 233.33%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -17.84 | -24.71 | -36.90 | -106.81 | -292.96 | -95.84 |
| YoY growth | -70.88% | -38.51% | -49.33% | -189.45% | -174.29% | -104.49% |
| Market Cap (mil) | 769.17 |
| P/E | |
| Forward P/E |
| EPS | -2.36 |
| Avg earnings growth rate | -104.49% |
| TTM earnings | -205.11 |